首页> 美国政府科技报告 >Review of Separately Billed Laboratory Tests Submitted by Spectra Laboratories for Medicare Beneficiaries with End-Stage Renal Disease Receiving Dialysis at Fresenius Medical Care North America's Facilities

【24h】

Review of Separately Billed Laboratory Tests Submitted by Spectra Laboratories for Medicare Beneficiaries with End-Stage Renal Disease Receiving Dialysis at Fresenius Medical Care North America's Facilities

机译：审查由spectra实验室提交的针对患有终末期肾病的医疗保险受益人在费森尤斯医疗北美医疗中心接受透析的单独实验室测试

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Medicare is a health insurance program administered by the Centers for Medicare & Medicaid Services (CMS). Medicare covers eligible beneficiaries who have end-stage renal disease (ESRD). CMS established a composite rate method of payment to reimburse dialysis facilities on a per treatment basis for outpatient maintenance dialysis services provided to ESRD beneficiaries. The composite rate is a comprehensive payment for most services related to dialysis treatment. CMS specifies the ESRD-related laboratory tests (hereafter referred to as tests) that are included in the composite rate and the frequencies (e.g., per treatment, weekly, or monthly) at which the tests are reimbursable as part of that rate. When the tests are performed at frequencies greater than specified, the additional tests are separately billable and payable if they are medically justified by accompanying documentation. In addition, certain routine tests that are not included as part of the composite rate may be billed separately, but payment for more than one of these tests performed in a 3-month period requires medical documentation.

著录项

作者

展开▼
作者单位

展开▼
年度 2010
页码 1-35
总页数 35
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Billing ; Laboratory tests ; Medicare ; Health insurance ; End-stage renal disease ; Dialysis ; Medical services ; Reimbursements ; Payments ; Documentation ; Health care facilities ; Outpatient clinics;

机译：计费;实验室检测;医疗保险;健康保险;终末期肾病;透析;医疗服务;报销;支付;文件;医疗保健设施;门诊诊所;

相似文献

外文文献

1. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease [J] . Grecia Marrufo, Erin Murphy Colligan, Brighita Negrusa, JAMA internal medicine . 2020,第6期

机译：综合末期肾病护理模型与止期肾病的医疗保险支付和保健质量
2. Medicare Enrollment Among Patients With End-Stage Kidney Disease Receiving Dialysis in Outpatient Facilities Between 2005 and 2016 [J] . JAMA: the Journal of the American Medical Association . 2020,第13期

机译：2005年至2016年间，在门诊设施中接受透析患者的医疗保险患者
3. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006鈥?015 [J] . Angela K. Shen, Jeffrey A. Kelman, Rob Warnock, Vaccine . 2017,第52期

机译：End-阶段肾病医疗保险人群中的受体特性和疫苗接种，索赔数据2006年的分析
4. ASSESSING MEDICAL SERVICE DELIVERY IN THE PUBLIC SECTOR: AN EVALUATION MODEL FOR THE END-STAGE RENAL DISEASE PROGRAM (MEDICARE). [D] . CLARK, NATHANIAL. 1984

机译：评估公共部门医疗服务的提供：终末期肾脏疾病计划（医疗）的评估模型。
5. Few Disparities in Baseline Laboratory Testing Following Diuretic or Digoxin Initiation by Medicare FFS Beneficiaries [O] . Matthew L. Maciejewski, Xiaojuan Mi, Lesley H. Curtis, -1

机译：Medicare FFS受益人在利尿剂或地高辛启动后基线实验室测试中的差异很少
6. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease [O] . Grecia Marrufo, Erin Murphy Colligan, Brighita Negrusa, 2020

机译：综合末期肾病护理模型与止期肾病的医疗保险支付和护理质量的关联
7. Laboratory Tests in End-Stage Renal Disease Patients Undergoing Dialysis. Health Technology Assessment, Number 2 [R] . Green, I. 1994

机译：终末期肾病患者接受透析的实验室检查。健康技术评估，第2号

Review of Separately Billed Laboratory Tests Submitted by Spectra Laboratories for Medicare Beneficiaries with End-Stage Renal Disease Receiving Dialysis at Fresenius Medical Care North America's Facilities

摘要

著录项

相似文献

相关主题

期刊订阅